Key Record Dates
ClinicalTrials.gov Identifier: | NCT03965494 |
---|---|
Brief Title: | AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery |
First Submitted : | May 24, 2019 |
First Submitted that Met QC Criteria : | May 24, 2019 |
First Posted : | May 29, 2019 |
Last Update Submitted that Met QC Criteria : | February 7, 2024 |
Last Update Posted : | February 8, 2024 |